MedTrace Logo

Oxytocin Effects on the Prosocial Learning

NCT04105140 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2019-09-26

No results posted yet for this study

Summary

To investigate whether intranasal oxytocin (24 IU) treatment can influence prosocial learning behavior in males.

Conditions

  • Healthy

Interventions

DRUG

Oxytocin

intranasal administration of oxytocin (24 IU)

DRUG

Placebo

intranasal administration of placebo (24 IU)

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Keith Kendrick, Dr. · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-08-10
Completion
2018-08-10

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04105140 on ClinicalTrials.gov